Flagship Harbor Advisors’s Lexicon Pharmaceuticals LXRX Stock Holding History

Flagship Harbor Advisors’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-428	Closed	–	–	1217
2020 Q3	$0	Hold	428	–	–	﹤0.01%	2070
2020 Q2	$0	Hold	428	–	–	﹤0.01%	2093
2020 Q1	$1K	Hold	428	–	–	﹤0.01%	1768
2019 Q4	$2K	Hold	428	–	–	﹤0.01%	1725
2019 Q3	$1K	Hold	428	–	–	﹤0.01%	1765
2019 Q2	$2K	Hold	428	–	–	﹤0.01%	1690
2019 Q1	$2K	Hold	428	–	–	﹤0.01%	1680
2018 Q4	$2K	Sell	428 -344	-45%	-$2.79K	﹤0.01%	1647
2018 Q3	$8K	Hold	772	–	–	﹤0.01%	1522
2018 Q2	$9K	Buy	+772	New	+$7.9K	﹤0.01%	1421

Other funds holding LXRX

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Flagship Harbor Advisors's LXRX Position: Q4 2020 in Review

Flagship Harbor Advisors sold out of Lexicon Pharmaceuticals (LXRX) in Q4 2020, closing a stake of 428 shares.

Flagship Harbor Advisors first reported a position in LXRX in Q2 2018 and held it in 10 quarters. The position peaked at $9K in Q2 2018. 106 funds tracked by Wall St. Rank hold LXRX as of Q4 2020.

Flagship Harbor Advisors reported no remaining Lexicon Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
Flagship Harbor Advisors sold 428 Lexicon Pharmaceuticals shares in Q4 2020.
Flagship Harbor Advisors first reported a position in Lexicon Pharmaceuticals in Q2 2018 and held it in 10 quarters.
Flagship Harbor Advisors's Lexicon Pharmaceuticals position peaked at $9K in Q2 2018.
106 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q4 2020.

Based on Flagship Harbor Advisors's 13F filing for Q4 2020, filed 8 Feb 2021.